Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis acquires ophthalmic drug from Takeda for $3.4bn

pharmaceutical-technologyJuly 04, 2019

Tag: Novartis , Acquires , Takeda

PharmaSources Customer Service